Company profile AVTE
After 39 days of this quarter the interest is at 18.0. Based on that we can calculate that during remaining 52 days it will total up to 42.0. aerovate therapeutics expected interest is significantly lower compared to previous quarter (-61.1%) and same quarter last year (-55.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 78 | 111 42.3% QoQ | 131 18.0% QoQ | 55 -58.0% QoQ |
| 2020 | 73 -6.4% YoY 32.7% QoQ | 115 3.6% YoY 57.5% QoQ | 20 -84.7% YoY -82.6% QoQ | 200 263.6% YoY 900.0% QoQ |
| 2021 | 71 -2.7% YoY -64.5% QoQ | 78 -32.2% YoY 9.9% QoQ | 179 795.0% YoY 129.5% QoQ | 101 -49.5% YoY -43.6% QoQ |
| 2022 | 86 21.1% YoY -14.9% QoQ | 59 -24.4% YoY -31.4% QoQ | 139 -22.3% YoY 135.6% QoQ | 231 128.7% YoY 66.2% QoQ |
| 2023 | 94 9.3% YoY -59.3% QoQ | 149 152.5% YoY 58.5% QoQ | 106 -23.7% YoY -28.9% QoQ | 108 -53.2% YoY 1.9% QoQ |
| 2024 | 18 -80.9% YoY -83.3% QoQ | - | - | - |
The average 5 years interest of aerovate therapeutics was 8.44 per week. The last year interest of aerovate therapeutics compared to the last 5 years has changed by -2.25%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 2.1%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. aerovate therapeutics stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 82 | 43 -47.6% QoQ | 87 102.3% QoQ | 61 -29.9% QoQ |
| 2020 | 86 4.9% YoY 41.0% QoQ | 52 20.9% YoY -39.5% QoQ | 69 -20.7% YoY 32.7% QoQ | 45 -26.2% YoY -34.8% QoQ |
| 2021 | 55 -36.0% YoY 22.2% QoQ | 51 -1.9% YoY -7.3% QoQ | 224 224.6% YoY 339.2% QoQ | 102 126.7% YoY -54.5% QoQ |
| 2022 | 59 7.3% YoY -42.2% QoQ | 88 72.5% YoY 49.2% QoQ | 44 -80.4% YoY -50.0% QoQ | 107 4.9% YoY 143.2% QoQ |
| 2023 | 72 22.0% YoY -32.7% QoQ | 22 -75.0% YoY -69.4% QoQ | 0 -100.0% YoY -100.0% QoQ | 58 -45.8% YoY inf% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of aerovate therapeutics stock was 5.39 per week. The last year interest of aerovate therapeutics stock compared to the last 5 years has changed by -50.83%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -61.59%.
There is not enough data for aerovate therapeutics news to provide analysis
There is not enough data for aerovate therapeutics news to provide correlation calculation
There is not enough data for aerovate therapeutics news to provide analysis
There is not enough data for aerovate therapeutics trial to provide analysis
There is not enough data for aerovate therapeutics trial to provide correlation calculation
There is not enough data for aerovate therapeutics trial to provide analysis
After 39 days of this quarter the interest is at 134.0. Based on that we can calculate that during remaining 52 days it will total up to 313.0. pulmonary arterial hypertension treatment expected interest is significantly higher compared to previous quarter (+117.4%) and same quarter last year (+112.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 68 | 33 -51.5% QoQ | 158 378.8% QoQ | 109 -31.0% QoQ |
| 2020 | 131 92.6% YoY 20.2% QoQ | 66 100.0% YoY -49.6% QoQ | 179 13.3% YoY 171.2% QoQ | 140 28.4% YoY -21.8% QoQ |
| 2021 | 29 -77.9% YoY -79.3% QoQ | 98 48.5% YoY 237.9% QoQ | 114 -36.3% YoY 16.3% QoQ | 45 -67.9% YoY -60.5% QoQ |
| 2022 | 59 103.4% YoY 31.1% QoQ | 11 -88.8% YoY -81.4% QoQ | 44 -61.4% YoY 300.0% QoQ | 99 120.0% YoY 125.0% QoQ |
| 2023 | 147 149.2% YoY 48.5% QoQ | 108 881.8% YoY -26.5% QoQ | 158 259.1% YoY 46.3% QoQ | 144 45.5% YoY -8.9% QoQ |
| 2024 | 134 -8.8% YoY -6.9% QoQ | - | - | - |
The average 5 years interest of pulmonary arterial hypertension treatment was 7.95 per week. The last year interest of pulmonary arterial hypertension treatment compared to the last 5 years has changed by 48.3%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 50.57%.
There is not enough data for dry powder inhaled formulation to provide analysis
There is not enough data for dry powder inhaled formulation to provide correlation calculation
There is not enough data for dry powder inhaled formulation to provide analysis
After 39 days of this quarter the interest is at 194.0. Based on that we can calculate that during remaining 52 days it will total up to 453.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 292 | 413 41.4% QoQ | 413 0.0% QoQ | 404 -2.2% QoQ |
| 2020 | 459 57.2% YoY 13.6% QoQ | 372 -9.9% YoY -19.0% QoQ | 422 2.2% YoY 13.4% QoQ | 374 -7.4% YoY -11.4% QoQ |
| 2021 | 394 -14.2% YoY 5.3% QoQ | 414 11.3% YoY 5.1% QoQ | 438 3.8% YoY 5.8% QoQ | 342 -8.6% YoY -21.9% QoQ |
| 2022 | 584 48.2% YoY 70.8% QoQ | 493 19.1% YoY -15.6% QoQ | 475 8.4% YoY -3.7% QoQ | 426 24.6% YoY -10.3% QoQ |
| 2023 | 451 -22.8% YoY 5.9% QoQ | 462 -6.3% YoY 2.4% QoQ | 398 -16.2% YoY -13.9% QoQ | 490 15.0% YoY 23.1% QoQ |
| 2024 | 194 -57.0% YoY -60.4% QoQ | - | - | - |
The average 5 years interest of imatinib was 33.37 per week. The last year interest of imatinib compared to the last 5 years has changed by 3.69%. The interest for imatinib is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 5.39%.
After 39 days of this quarter the interest is at 69.0. Based on that we can calculate that during remaining 52 days it will total up to 161.0. AV-101 expected interest is significantly higher compared to previous quarter (+78.9%) and same quarter last year (+168.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 113 | 38 -66.4% QoQ | 0 -100.0% QoQ | 70 inf% QoQ |
| 2020 | 168 48.7% YoY 140.0% QoQ | 190 400.0% YoY 13.1% QoQ | 23 inf% YoY -87.9% QoQ | 49 -30.0% YoY 113.0% QoQ |
| 2021 | 80 -52.4% YoY 63.3% QoQ | 268 41.1% YoY 235.0% QoQ | 188 717.4% YoY -29.9% QoQ | 139 183.7% YoY -26.1% QoQ |
| 2022 | 120 50.0% YoY -13.7% QoQ | 201 -25.0% YoY 67.5% QoQ | 105 -44.1% YoY -47.8% QoQ | 36 -74.1% YoY -65.7% QoQ |
| 2023 | 60 -50.0% YoY 66.7% QoQ | 147 -26.9% YoY 145.0% QoQ | 228 117.1% YoY 55.1% QoQ | 90 150.0% YoY -60.5% QoQ |
| 2024 | 69 15.0% YoY -23.3% QoQ | - | - | - |
The average 5 years interest of AV-101 was 9.13 per week. The last year interest of AV-101 compared to the last 5 years has changed by 25.08%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 112.66%.
There is not enough data for rare cardiopulmonary diseases to provide analysis
There is not enough data for rare cardiopulmonary diseases to provide correlation calculation
There is not enough data for rare cardiopulmonary diseases to provide analysis